First-line thrombectomy strategy for distal and medium vessel occlusions: a systematic review

医学 放射科 外科 心脏病学
作者
Cem Bilgin,Nicole Hardy,Kristen Hutchison,John M. Pederson,Alexander Mebane,Peace Olaniran,Hassan Kobeissi,Kevin M. Kallmes,David Fiorella,David F. Kallmes,Waleed Brinjikji
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:15 (6): 539-546 被引量:58
标识
DOI:10.1136/jnis-2022-019344
摘要

Background The benefit of mechanical thrombectomy (MT) and efficacy of different first-line MT techniques remain unclear for distal and medium vessel occlusions (DMVOs). In this systematic review, we aimed to compare the performance of three first-line MT techniques in DMVOs. Methods The PubMed database was searched for studies examining the utility of MT in DMVOs (middle cerebral artery M2-3-4, anterior cerebral artery, and posterior cerebral artery). Studies providing data for aspiration thrombectomy (ASP), stent retriever thrombectomy (SR), and combined SR+ASP technique were included. Non-comparative studies were excluded. Safety and efficacy data were collected for each technique. The Nested Knowledge AutoLit platform was utilized for literature search, screening, and data extraction. Pooled data were presented as descriptive statistics. Results 13 studies comprising 2422 MT procedures were identified. The overall successful recanalization rate was 77.0% (1513/1964) for DMVOs. SR+ASP had a successful recanalization rate of 83.7% (297/355), SR had a 75.6% rate (638/844), while ASP alone had a 74.2% rate (386/520). The overall functional independence rate was 51.3% (851/1659) among DMVOs. The ASP alone group had a functional independence rate of 46.9% (219/467), while functional independence rates of the SR and SR+ASP groups were 51.5% (372/723) and 61.7% (174/282), respectively. Finally, the subarachnoid hemorrhage rates were 1.8% (4/217) for the ASP group, 9.3% (26/281) for the SR group, and 11.9% (41/344) for the SR+ASP group. Conclusions Our systematic review supports the proposition that MT is a safe and effective treatment option for DMVOs. Additionally, while the SR+ASP group had consistently high rates of clot clearance and good neurological outcomes, the SR and SR+ASP groups also had higher rates of subarachnoid hemorrhage, highlighting the need for improved DMVO treatment devices.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小送完成签到,获得积分10
刚刚
Owen应助怕黑三毒采纳,获得10
刚刚
爱意随风起完成签到 ,获得积分10
1秒前
1秒前
kinji发布了新的文献求助10
1秒前
时尚蜻蜓发布了新的文献求助10
2秒前
啵子发布了新的文献求助10
2秒前
2秒前
董伟业完成签到,获得积分10
4秒前
Lucas应助banana采纳,获得10
5秒前
852应助banana采纳,获得10
5秒前
脑洞疼应助wenxianqiuzhu采纳,获得10
6秒前
阿衍完成签到,获得积分10
7秒前
7秒前
无花果应助CANDICE采纳,获得10
7秒前
乐意梨发布了新的文献求助10
7秒前
songflower发布了新的文献求助10
8秒前
mingjie发布了新的文献求助10
8秒前
啵子完成签到,获得积分10
8秒前
8秒前
9秒前
superchen完成签到,获得积分10
10秒前
10秒前
太阳雨完成签到,获得积分10
10秒前
全都一次过完成签到 ,获得积分10
11秒前
潇澜完成签到,获得积分10
11秒前
1111发布了新的文献求助10
11秒前
大方糖豆完成签到 ,获得积分10
11秒前
摆烂受体阻断剂完成签到,获得积分10
12秒前
perrier发布了新的文献求助10
12秒前
伍秋望完成签到,获得积分10
12秒前
13秒前
13秒前
明芷蝶完成签到,获得积分10
14秒前
太阳雨发布了新的文献求助10
14秒前
lijiabo发布了新的文献求助10
15秒前
希妍完成签到,获得积分20
16秒前
xiaoming发布了新的文献求助10
17秒前
1195089545完成签到 ,获得积分10
17秒前
顾矜应助Pelvicachromis采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
The Effective Clinical Neurologist 3ed 500
The Great Hymn to Šamaš 500
Positive Obsession: The Life and Times of Octavia E. Butler 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7698689
求助须知:如何正确求助?哪些是违规求助? 9258248
关于积分的说明 20013444
捐赠科研通 7273811
什么是DOI,文献DOI怎么找? 3293360
关于科研通互助平台的介绍 2448775
邀请新用户注册赠送积分活动 2299533